Transcription
COMPANY PROFILE
Our m ission is to im prove patients’ livesby identif yin g , developin g , an dcom m ercia lizin g m eanin gful produc ts thata ddress unm et m edic al needs .
Who We AreWhere there’s a will, there’s a way. Patients are our will.Jazz Pharmaceuticals plc is an international biopharmaceutical company focusedon improving patients’ lives by identifying, developing, and commercializingmeaningful products that address unmet medical needs.We have a diverse portfolio of products and product candidates, with a focus in theareas of sleep and hematology/oncology. We also support commercial products inother therapeutic areas where we can meaningfully address serious medical needs.As part of our unwavering commitment to improve patients’ lives, we are continuingto expand our commercial product portfolio and our research and developmentpipeline in therapeutic areas that can leverage our unique expertise. We do thisthrough a growth strategy of growing sales of the existing medicines in our portfolio;acquiring commercial products or product candidates that are in late-stagedevelopment; and pursuing focused development of our pipeline of differentiatedtherapies.
O ur CultureWe have a strong patient-focused culture at Jazz Pharmaceuticals that ouremployees believe in and pursue every day. It is clearly identified through ourmission, vision and core values.Each member of our team makes integral contributions and is working toward acommon goal to improve patients' lives.Everything we do at Jazz Pharmaceuticals is focused on three things: Putting patients first Being a great place to work Living our core values — integrity, collaboration, passion, pursuit of excellenceand innovation
Produc tsWe have a diverse portfolio of products in our therapeutic areas of focus:sleep and hematology/oncology.We also support commercial products in therapeutic areas where we canmeaningfully address serious medical needs. Our products are reaching patientsin over 80 countries.
Research an d Developm entAt Jazz Pharmaceuticals, we strive to identify and develop new, meaningfulproducts that fill significant unmet medical needs of patients. We are activelyexpanding global R&D capabilities and advancing our clinical pipeline intherapeutic areas that leverage our expertise.Our research and development program currently includes clinical developmentprograms in the areas of sleep and hematology/oncology for new productcandidates, line extensions for existing products and the generation of additionalclinical data for existing products.
OurLea dershipOur leadership team has a proven track record of successfully developing andcommercializing therapeutics and creating patient programs that result in betterpatient care.At the same time, they’ve demonstrated their ability to drive shareholder value andbuilt Jazz Pharmaceuticals into an employer of choice. The following individualscomprise Jazz Pharmaceuticals’ Executive Committee. See JazzPharmaceuticals.comfor biographies and a listing of the company’s Board of Directors.Bruce C. CozaddChairman and Chief Executive OfficerRobert McKagueSenior Vice Presidentand Chief Compliance OfficerRussell J. CoxExecutive Vice Presidentand Chief Operating OfficerMichael P. MillerSenior Vice President, US CommercialSuzanne Sawochka HooperExecutive Vice Presidentand General CounselKaren Smith, M.D., Ph.D., M.B.A., L.L.M.Global Head of Research and Developmentand Chief Medical OfficerHeather McGaugheySenior Vice President,Human ResourcesPaul TreacySenior Vice President,Technical OperationsIain McGillSenior Vice President,Jazz Pharmaceuticals Europe and Rest of WorldMatthew YoungExecutive Vice Presidentand Chief Financial Officer
Our Philanthropic Responsibilit yAt Jazz Pharmaceuticals, we view our corporate giving as an opportunity for us tohelp improve patients’ lives by filling unmet needs, to demonstrate our commitmentto the communities we serve by building powerful collaborations, and to make animpact through meaningful investments in organizations, initiatives and causes thatreflect our mission, values, and strategic focus.Jazz is committed to supporting programs through educational grants, sponsorships andresearch that benefits patients and the scientific or medical community. These supportedprograms are healthcare-related and consistent with Jazz Pharmaceuticals’ therapeuticsareas of focus. We are also committed to being an exemplary corporate citizen andcontributing to the well-being of the communities in which we live and work.Funding Areas of Focus Include: Healthcare-related charitable support Philanthropic charitable support Independent medical education
OurH istor y20032003/2004Jazz Pharmaceuticals foundedManagement team assembled/capital raised2005Acquired Orphan Medical and its product, Xyrem 2007Launch of Luvox CR 2012Merger with Azur Pharma, which changed Jazz Pharmaceuticals in manyways, including providing new global headquarters in Dublin, Ireland,brining in new employees and new members of our management team andexpanding our product offerings by bringing Prialt into the company2012Acquired EUSA Pharma, which extended our product offeringsto include Erwinaze /Erwinase and helped us establish our Europeancommercial infrastructure2013License agreement with Concert Pharmaceuticals for the rights to JZP-3862014Broke ground on manufacturing facility in Ireland2014Acquired rights to JZP-110 from Aerial BioPharma2014Acquired Gentium, which added Defitelio (defibrotide) to our productportfolio; European commercial launch of Defitelio2014Acquired rights to defibrotide in the Americas from Sigma-Tau Pharma2015JZP-110 Phase 3 clinical program initiated2016US launch of Defitelio (defibrotide sodium)
What ’s in Our N am e?The name "Jazz Pharmaceuticals" was inspired by the talented jazz musicians whocome together — each a musical specialist with an individual style — to make musicin concert that is greater than the sum of its parts. Each talented member of our team,working collaboratively, comes together to contribute to a common goal: improvingpatients’ lives.
Jazz Direct MarketPartner MarketOur G lobal Rea chHeadquartered in Dublin, Ireland, we have over 880 employees workingcollaboratively across multiple offices in the US and EU to reach patients in thenumerous countries in which our products are available.We have operations in the following locations:Dublin, IrelandOxford, EnglandLyon, FranceMunich, GermanyPalo Alto, California, USAPhiladelphia, Pennsylvania, USAVilla Guardia, Italy
For more information about Jazz Pharmaceuticals,please visit JazzPharmaceuticals.com.
COMPANY PROFILE. Our mission is to improve patients’ lives by identif ying, develop ing, and comme rcializ ing meaningful products that address unmet medical needs . Who We Are Where there’s a will, there’s a way. Patients are our will. Jazz Pharma ceuticals plc is an int ernational biop harma ceutical company focus ed on improving patien ts’ lives by iden tifying, develop ing, and .
